Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tregs”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Early research (Phase 1)Temporarily pausedNCT05993611
What this trial is testing

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 27
Not applicableUnknownNCT05569096
What this trial is testing

Tregs CD25 CXCL9 in Vitiligo

Who this might be right for
VitiligoCD25 DeficiencyChemokine (C-X-C Motif)+1 more
Assiut University 40
Early research (Phase 1)Study completedNCT01210664
What this trial is testing

T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs

Who this might be right for
Type 1 Diabetes Mellitus
University of California, San Francisco 16
Testing effectiveness (Phase 2)Looking for participantsNCT06688331
What this trial is testing

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

Who this might be right for
Presymptomatic Diabetes Type 1 (Stage 1)Diabetes Mellitus, Type IDiabetes Mellitus, Type 1
PolTREG S.A. 150
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Post-approval studies (Phase 4)UnknownNCT05340985
What this trial is testing

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingAdult ALLVitamin D3 Deficiency
Tehran University of Medical Sciences 54
Not applicableStudy completedNCT02186522
What this trial is testing

Immune Failure in Critical Therapy (INFECT) Study

Who this might be right for
SepsisSeptic Shock
University of Edinburgh 168
Testing effectiveness (Phase 2)Study completedNCT01581970
What this trial is testing

Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Masonic Cancer Center, University of Minnesota 7
Not applicableStudy completedNCT02581579
What this trial is testing

Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection

Who this might be right for
Tuberculosis
Manresana de Micobacteriologia, SL 24
Early research (Phase 1)Ended earlyNCT02428309
What this trial is testing

Autologous Polyclonal Tregs for Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic
National Institute of Allergy and Infectious Diseases (NIAID) 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03577431
What this trial is testing

Liver Transplantation With Tregs at MGH

Who this might be right for
Liver Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 9
Testing effectiveness (Phase 2)Study completedNCT02711826
What this trial is testing

Treg Therapy in Subclinical Inflammation in Kidney Transplantation

Who this might be right for
Kidney TransplantAdult Living Donor Kidney Transplant RecipientsRenal Transplant+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Looking for participantsNCT06671236
What this trial is testing

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Novabio Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT04433585
What this trial is testing

LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Nektar Therapeutics 291
Not applicableStudy completedNCT00555178
What this trial is testing

Regulatory T Cells (Tregs) in Polymorphic Light Eruption

Who this might be right for
Polymorphic Light EruptionPsoriasisAtopic Eczema
Medical University of Graz 92
Testing effectiveness (Phase 2)Study completedNCT02474199
What this trial is testing

Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

Who this might be right for
Liver Transplant RecipientLiving Donor (of the Respective Liver Transplant Recipient)
National Institute of Allergy and Infectious Diseases (NIAID) 15
Not applicableStudy completedNCT02317133
What this trial is testing

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

Who this might be right for
Henoch Schönlein Purpura
Centre Hospitalier Universitaire de Nīmes 100
Not applicableNot Yet RecruitingNCT07171307
What this trial is testing

Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy

Who this might be right for
Conjunctivitis, Allergic
Instituto de Oftalmología Fundación Conde de Valenciana 60
Early research (Phase 1)Study completedNCT00675831
What this trial is testing

Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT02088931
What this trial is testing

Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation

Who this might be right for
Late Complication From Kidney Transplant
University of California, San Francisco 3
Load More Results